Bausch Health Companies (BHC) Amortizatization of Intangibles (2009 - 2012)
Bausch Health Companies' (BHC) quarterly Amortizatization of Intangibles came in at $3.2 million in Q1 2012, up 22.98% year-over-year from $2.6 million in Q2 2011, and up 63.51% quarter-over-quarter from $2.0 million in Q4 2011.
Analysis
Bausch Health Companies (BHC) Amortizatization of Intangibles (2009 - 2012) Analysis & Trends
Bausch Health Companies has disclosed Amortizatization of Intangibles across 4 years of filings, most recently posting $3.2 million for Q1 2012.
- In Q1 2012, Amortizatization of Intangibles rose 22.98% year-over-year to $3.2 million; the TTM figure through Mar 2012 stood at $9.1 million (down 17.37% YoY), while the FY2011 annual figure was $8.5 million, down 23.98% from the prior year.
- Amortizatization of Intangibles came in at $3.2 million for Q1 2012 at Bausch Health Companies, up from $2.0 million in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $3.2 million in Q1 2012 to a low of $564000.0 in Q2 2009.
- Average Amortizatization of Intangibles over 4 years is $2.4 million, with a median of $2.7 million recorded in 2009.
- Year-over-year, Amortizatization of Intangibles surged 403.01% in 2010 and sank 31.44% in 2011.
- Over 4 years, Amortizatization of Intangibles stood at $2.7 million in 2009, then increased by 2.88% to $2.8 million in 2010, then decreased by 29.51% to $2.0 million in 2011, then surged by 63.51% to $3.2 million in 2012.
- Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $3.2 million in Q1 2012, $2.0 million in Q4 2011, and $1.9 million in Q3 2011.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | - |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | - |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | - |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 456,000.00 |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 2.15 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2012 | 3.25 Mn |
| Dec 31, 2011 | 1.99 Mn |
| Sep 30, 2011 | 1.92 Mn |
| Jun 30, 2011 | 1.95 Mn |
| Mar 31, 2011 | 2.64 Mn |
| Dec 31, 2010 | 2.82 Mn |
| Sep 30, 2010 | 2.71 Mn |
| Jun 30, 2010 | 2.84 Mn |
| Mar 31, 2010 | 2.80 Mn |
| Dec 31, 2009 | 2.74 Mn |
| Sep 30, 2009 | 2.68 Mn |
| Jun 30, 2009 | 564,000.00 |